WuXi Biologics (Cayman) Inc
HKEX:2269
WuXi Biologics (Cayman) Inc
HKEX:2269
Price:
34.42
HKD
-1.99%
Market Closed
Market Cap:
HK$142.4B
Cash Flow Statement
Cash Flow Statement
WuXi Biologics (Cayman) Inc
WuXi Biologics (Cayman) Inc
Currency: CNY
| Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
304
|
0
|
738
|
0
|
1 127
|
0
|
1 966
|
0
|
3 993
|
0
|
5 358
|
0
|
4 174
|
0
|
4 834
|
0
|
|
| Depreciation & Amortization |
87
|
0
|
142
|
0
|
221
|
0
|
303
|
0
|
482
|
0
|
801
|
0
|
1 169
|
0
|
1 437
|
0
|
|
| Stock-Based Compensation |
65
|
87
|
128
|
158
|
204
|
250
|
284
|
0
|
578
|
1 177
|
1 297
|
1 480
|
1 424
|
1 331
|
1 209
|
988
|
|
| Other Non-Cash Items |
127
|
0
|
180
|
0
|
154
|
0
|
74
|
0
|
270
|
0
|
943
|
0
|
1 003
|
0
|
839
|
0
|
|
| Cash Taxes Paid |
43
|
0
|
52
|
0
|
78
|
0
|
94
|
0
|
350
|
0
|
586
|
0
|
783
|
0
|
1 092
|
0
|
|
| Cash Interest Paid |
37
|
5
|
0
|
6
|
50
|
80
|
83
|
88
|
83
|
86
|
108
|
174
|
217
|
207
|
201
|
193
|
|
| Change in Working Capital |
(158)
|
6
|
(298)
|
861
|
(294)
|
1 417
|
(461)
|
2 249
|
(1 313)
|
4 091
|
(1 560)
|
6 834
|
(1 679)
|
3 220
|
(1 893)
|
5 722
|
|
| Cash from Operating Activities |
360
N/A
|
255
-29%
|
762
+199%
|
861
+13%
|
1 208
+40%
|
1 417
+17%
|
1 881
+33%
|
2 249
+20%
|
3 431
+53%
|
4 091
+19%
|
5 542
+35%
|
6 834
+23%
|
4 668
-32%
|
3 220
-31%
|
5 217
+62%
|
5 722
+10%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(671)
|
(1 334)
|
(1 674)
|
(1 592)
|
(3 235)
|
(5 371)
|
(6 025)
|
(7 185)
|
(6 523)
|
(5 134)
|
(5 868)
|
(5 739)
|
(4 221)
|
(3 533)
|
(3 930)
|
(3 963)
|
|
| Other Items |
(1 543)
|
(150)
|
1 258
|
(805)
|
(1 259)
|
(1 707)
|
(1 192)
|
(3 742)
|
(3 079)
|
911
|
(40)
|
604
|
992
|
1 512
|
(12)
|
(135)
|
|
| Cash from Investing Activities |
(2 213)
N/A
|
(1 484)
+33%
|
(416)
+72%
|
(2 397)
-476%
|
(4 494)
-87%
|
(7 078)
-57%
|
(7 216)
-2%
|
(10 927)
-51%
|
(9 602)
+12%
|
(4 223)
+56%
|
(5 908)
-40%
|
(5 135)
+13%
|
(3 228)
+37%
|
(2 022)
+37%
|
(3 942)
-95%
|
(4 097)
-4%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
3 573
|
3 201
|
3 206
|
5
|
3 534
|
0
|
5 585
|
16 562
|
8 461
|
(3 208)
|
(2 804)
|
(2 113)
|
2 687
|
1 453
|
(1 766)
|
(1 563)
|
|
| Net Issuance of Debt |
(903)
|
(1 201)
|
0
|
(9)
|
1 888
|
2 901
|
821
|
144
|
(147)
|
(485)
|
(295)
|
(406)
|
(818)
|
(765)
|
310
|
382
|
|
| Other |
(441)
|
(6)
|
1
|
14
|
(8)
|
18
|
160
|
31
|
(104)
|
468
|
508
|
(41)
|
93
|
(14)
|
(1 294)
|
(1 179)
|
|
| Cash from Financing Activities |
2 229
N/A
|
1 994
-11%
|
3 207
+61%
|
10
-100%
|
5 413
+54 920%
|
6 453
+19%
|
6 566
+2%
|
16 737
+155%
|
8 209
-51%
|
(3 225)
N/A
|
(2 592)
+20%
|
(2 561)
+1%
|
1 961
N/A
|
674
-66%
|
(2 750)
N/A
|
(2 360)
+14%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(42)
|
(13)
|
28
|
19
|
(6)
|
53
|
(340)
|
(487)
|
(132)
|
210
|
350
|
81
|
(126)
|
(73)
|
84
|
21
|
|
| Net Change in Cash |
335
N/A
|
751
+124%
|
3 581
+377%
|
(1 507)
N/A
|
2 121
N/A
|
846
-60%
|
890
+5%
|
7 572
+751%
|
1 908
-75%
|
(3 146)
N/A
|
(2 608)
+17%
|
(780)
+70%
|
3 275
N/A
|
1 798
-45%
|
(1 391)
N/A
|
(714)
+49%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(310)
N/A
|
(1 079)
-248%
|
(912)
+15%
|
(731)
+20%
|
(2 027)
-177%
|
(3 954)
-95%
|
(4 144)
-5%
|
(4 936)
-19%
|
(3 092)
+37%
|
(1 043)
+66%
|
(327)
+69%
|
1 095
N/A
|
447
-59%
|
(313)
N/A
|
1 288
N/A
|
1 759
+37%
|
|
Switch to:
Switch to:
See Also
Discover More
